Skip to main content
UniHealth

Doctor search

Amir Tabatabai, MD

Hematology/Oncology · Los Gatos

NPI 1871592154

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
7
3 carriers
Offices
2

Offices

2 locations · Monterey Bay Oncology A Medical Corporation · Dignity Health Medical Foundation

Looking this up.

Hospitals listed: Dominican Hospital · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

7 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tabatabai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

7 of 7 plans

Plans whose provider directory lists this clinician
Advantage Care (HMO)Align Senior CareListedOct 1, 2026
Premier Care (HMO I-SNP)Align Senior CareListedOct 1, 2026
Senior Care (HMO I-SNP)Align Senior CareListedOct 1, 2026
Astiva Health C-SNP WOW - NorCal (HMO C-SNP)Astiva HealthListedSep 27, 2026
Astiva Health Premier Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Astiva Health Savings Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Dominican Hospital

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Dominican Hospital
Postoperative sepsis rateComplications and deaths11.66 (8.02 to 15.3) · 412 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.168BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.169BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.489BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.01 (0.06 to 1.95) · 1,248 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.14 (0.85 to 1.43)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths134.37 (94.33 to 174.41) · 132 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.4 · 54 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.2 · 137 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12 · 228 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.5 · 534 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.8 · 491 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 278 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.4 · 2,973 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.14 (0 to 0.34) · 7,510 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,695 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.42 (1.44 to 5.4) · 1,594 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.26 (0 to 2.76) · 436 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.85 (0.4 to 3.29) · 1,474 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.73 (3 to 14.46) · 437 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.58 (0.13 to 3.03) · 343 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.57 (0 to 1.17) · 6,336 casesNo differentJul 2022 – Jun 2024
MRSA BacteremiaInfections0.615No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.937No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 212 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 505 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits45 · 237 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-13.5 · 594 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits1.9 · 510 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.9 · 473 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (3.4 to 7.8) · 126 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13 (9.4 to 17.7) · 126 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits12.7 · 43 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.7 · 143 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.1 (9.4 to 15.4) · 1,585 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.3) · 390 casesNo differentJan 2024 – Dec 2024

What patients said (774 patients answered, 23% of those asked)

Patient survey stars by topic at Dominican Hospital
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness1
Recommend hospital4
Share of patients giving the best answer at Dominican Hospital
Room was "always" clean73%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand77%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand76%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night32%
"YES", patients would definitely recommend the hospital68%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$665,709

Medicare paid this office $665,709 for 503 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, daratumumab, 10 mg and hyaluronidase-fihj11$75,718None
Injection, denosumab, 1 mg15$44,664None
Long return visit (40+ min)124$29,070$132
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg13$16,086$96
Return visit (30+ min)138$13,332$84
See all 35 services
Every Original Medicare service billed
Injection, daratumumab, 10 mg and hyaluronidase-fihj11$75,718None
Injection, denosumab, 1 mg15$44,664None
Long return visit (40+ min)124$29,070$132
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg13$16,086$96
Return visit (30+ min)138$13,332$84
New patient visit (60+ min)73$13,029$178
Injection, darbepoetin alfa, 1 microgram (non-esrd use)11$8,372None
Short return visit (20+ min)103$7,415$66
Administration of chemotherapy into vein, 1 hour or less50$5,989$92
Insertion of needle into vein for collection of blood sample123$2,232$9
Blood test, comprehensive group of blood chemicals96$2,039$10
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count116$1,843$8
New patient visit (45+ min)14$1,671$119
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less35$1,587$21
Initial hospital care with moderate level of medical decision making at least 75 minutes18$1,429$79
Administration of additional new drug or substance into vein, 1 hour or less20$1,286$46
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle19$982$47
Injection of drug or substance under skin or into muscle57$899$11
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or18$772$27
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less15$650$43
Blood test, thyroid stimulating hormone (tsh)22$527$16
Injection of additional new drug or substance into vein25$490$11
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle12$436$27
Administration of chemotherapy into vein, each additional hour16$423$20
Psa (prostate specific antigen) measurement, total12$414$18
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour11$268$15
Ferritin (blood protein) level18$267$13
Injection, palonosetron hcl, 25 mcg22$166None
Lactate dehydrogenase (enzyme) level16$160$6
Iron binding capacity15$154$9
Magnesium level14$145$7
Iron level16$120$6
Injection, granisetron hydrochloride, 100 mcg13$54None
Injection, dexamethasone sodium phosphate, 1 mg25$34None
Injection, diphenhydramine hcl, up to 50 mg12$9None

Who their Medicare patients are

503 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 14% · Women 56% · Also on Medicaid 13% · Health risk score 2.36. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 75% · Cancer 50% · Chronic kidney disease 36% · Coronary heart disease 32% · Diabetes 28% · Depression 27% · Atrial fibrillation 25% · Heart failure 21% · COPD 17% · Stroke 8% · Dementia 6%.

The office billed $1,594,502, Medicare allowed $848,795 and paid $665,709; for 31,663 services of 126 kinds; $572,572 of it was for drugs given in the office and $93,137 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202450331,663752.36$1,594,502$665,709
2023711136,676752.55$5,384,490$2,629,350
2022840180,184752.30$6,730,816$3,309,335
2021897134,277742.36$5,385,821$2,836,408
2020760144,087742.47$4,206,907$2,148,463
2019895180,334742.42$4,998,992$2,530,484
2018822149,557742.25$4,247,229$2,148,539
2017898179,536742.12$4,449,426$2,204,979
2016814189,044742.29$4,675,225$2,249,241
2015859189,776742.11$4,878,892$2,193,490
2014860186,450742.09$5,029,059$2,225,241
2013753170,236741.98$4,420,172$1,934,156

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 64 services

Original Medicare services billed in 2023
Injection, pembrolizumab, 1 mg28$483,500None
Injection, daratumumab, 10 mg and hyaluronidase-fihj22$303,474None
Injection, nivolumab, 1 mg13$176,998None
Injection, denosumab, 1 mg43$112,306None
Long return visit (40+ min)186$58,970$130
Injection, ferric derisomaltose, 10 mg27$47,387None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)43$45,745None
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg26$45,421$102
Administration of chemotherapy into vein, 1 hour or less169$28,925$98
Return visit (30+ min)158$20,518$88
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg17$15,797$73
Injection, bortezomib, 0.1 mg15$10,485None
Insertion of needle into vein for collection of blood sample246$9,091$8
Initial hospital care with moderate level of medical decision making at least 75 minutes63$8,543$136
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count245$8,439$8
Blood test, comprehensive group of blood chemicals169$8,017$10
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less114$7,521$21
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle40$7,036$54
Short return visit (20+ min)93$6,087$56
New patient visit (60+ min)31$5,222$168
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l19$4,851$128
Injection, fulvestrant, 25 mg15$4,592None
Administration of additional new drug or substance into vein, 1 hour or less55$4,189$49
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less55$3,010$46
Administration of chemotherapy into vein, each additional hour57$2,971$21
Injection of drug or substance under skin or into muscle145$2,737$11
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$2,512$93
Injection of additional new drug or substance into vein77$2,074$11
Injection, azacitidine, 1 mg11$2,001None
Blood test, thyroid stimulating hormone (tsh)36$1,778$16
Administration of additional new drug or substance into vein using push technique25$1,536$40
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-311$1,407$20
Psa (prostate specific antigen) measurement, total18$1,153$18
Injection, leucovorin calcium, per 50 mg14$1,140None
Carcinoembryonic antigen (cea) protein level21$1,040$19
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle25$1,033$26
Injection, palonosetron hcl, 25 mcg74$1,009None
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour23$990$15
Infusion into a vein for hydration, 31-60 minutes22$942$25
Ferritin (blood protein) level38$828$13
Magnesium level36$756$7
Infusion into a vein for hydration, each additional hour29$721$10
Injection, fosaprepitant, 1 mg27$685None
Injection, fluorouracil, 500 mg19$631None
Office for the evaluation and management of established patient that may not require presence of healthcare professional33$621$17
Injection, zoledronic acid, 1 mg17$544None
Injection, irinotecan, 20 mg12$531None
Iron binding capacity34$497$9
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg19$462None
Injection, oxaliplatin, 0.5 mg12$391None
Lactate dehydrogenase (enzyme) level34$379$6
Iron level34$368$6
Injection, paclitaxel, 1 mg15$353None
Irrigation of implanted venous access drug delivery device18$347$17
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion12$334$15
Injection, carboplatin, 50 mg18$324None
Injection, dexamethasone sodium phosphate, 1 mg94$199None
Injection, granisetron hydrochloride, 100 mcg30$110None
Injection, atropine sulfate, 0.01 mg16$93None
Injection, diphenhydramine hcl, up to 50 mg53$67None
Blood creatinine level11$55$5
Infusion, normal saline solution, sterile (500 ml = 1 unit)21$51None
Infusion, normal saline solution , 1000 cc11$33None
Unclassified drugs30$27None

2022: 76 services

Original Medicare services billed in 2022
Injection, pembrolizumab, 1 mg28$649,407None
Injection, daratumumab, 10 mg and hyaluronidase-fihj25$314,501None
Injection, nivolumab, 1 mg19$304,992None
Injection, denosumab, 1 mg53$124,499None
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg40$102,315$133
Injection, bortezomib, 0.1 mg23$102,050None
Injection, paclitaxel protein-bound particles, 1 mg13$93,300None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)54$85,599None
Long return visit (40+ min)251$81,629$132
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg19$66,217$36
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg19$59,453$36
Injection, ferric derisomaltose, 10 mg25$50,628None
Administration of chemotherapy into vein, 1 hour or less201$45,123$105
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg11$35,053None
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a65$31,299$160
Return visit (30+ min)186$23,192$88
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less142$12,459$23
Initial hospital care with moderate level of medical decision making at least 75 minutes67$10,700$155
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle61$10,464$56
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count362$9,814$8
New patient visit (60+ min)60$9,595$160
Blood test, comprehensive group of blood chemicals229$9,113$10
Short return visit (20+ min)123$8,825$62
Cyclophosphamide, 100 mg17$7,672None
Administration of additional new drug or substance into vein, 1 hour or less61$6,975$51
Injection, fulvestrant, 25 mg15$6,025None
Injection, azacitidine, 1 mg14$5,599None
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes33$5,059$80
Leuprolide acetate (for depot suspension), 7.5 mg13$4,923None
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less66$4,191$49
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l21$3,836$128
Insertion of needle into vein for collection of blood sample317$3,503$3
Injection of drug or substance under skin or into muscle170$3,445$11
Blood test, thyroid stimulating hormone (tsh)49$2,454$17
Administration of additional new drug or substance into vein using push technique31$2,448$45
Injection of additional new drug or substance into vein92$2,410$12
Administration of chemotherapy into vein, each additional hour50$2,307$23
Administration of chemotherapy into vein using push technique18$2,276$81
Infusion into a vein for hydration, 31-60 minutes54$2,127$26
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-314$1,912$21
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$1,843$56
Infusion into a vein for hydration, each additional hour59$1,695$10
Psa (prostate specific antigen) measurement, total17$1,380$18
Ferritin (blood protein) level66$1,318$13
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle30$1,235$24
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg21$1,232None
Office for the evaluation and management of established patient that may not require presence of healthcare professional55$1,114$17
Injection, palonosetron hcl, 25 mcg86$1,106None
Magnesium level57$866$7
Injection, fosaprepitant, 1 mg26$852None
Injection, zoledronic acid, 1 mg23$791None
Injection, leucovorin calcium, per 50 mg23$783None
Carcinoembryonic antigen (cea) protein level14$769$19
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour18$752$16
Lactate dehydrogenase (enzyme) level63$608$6
Iron binding capacity45$587$9
Injection, fluorouracil, 500 mg26$527None
Irrigation of implanted venous access drug delivery device23$452$17
Iron level45$434$6
Injection, carboplatin, 50 mg19$412None
Injection, granisetron hydrochloride, 100 mcg44$345None
Injection, oxaliplatin, 0.5 mg14$336None
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion14$302$16
Injection, dexamethasone sodium phosphate, 1 mg116$285None
Blood test, basic group of blood chemicals (calcium, total)28$283$8
Injection, paclitaxel, 1 mg12$276None
Infusion, normal saline solution , 1000 cc50$239None
Calcium level, total15$97$5
Injection, diphenhydramine hcl, up to 50 mg66$93None
Uric acid level, blood15$89$4
Blood creatinine level16$86$5
Phosphate level12$75$5
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg17$44None
Injection, atropine sulfate, 0.01 mg12$38None
Infusion, normal saline solution, sterile (500 ml = 1 unit)17$33None
Unclassified drugs33$28None

2021: 79 services

Original Medicare services billed in 2021
Injection, pembrolizumab, 1 mg23$363,286None
Injection, daratumumab, 10 mg and hyaluronidase-fihj20$264,024None
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a164$150,796$161
Injection, nivolumab, 1 mg11$142,230None
Injection, denosumab, 1 mg57$112,154None
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg36$109,974$183
Injection, bortezomib, 0.1 mg23$102,064None
Long return visit (40+ min)296$80,357$136
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg14$73,689$50
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg18$66,548$44
Injection, darbepoetin alfa, 1 microgram (non-esrd use)47$63,126None
Injection, ferric derisomaltose, 10 mg26$54,755None
Administration of chemotherapy into vein, 1 hour or less178$40,349$112
Return visit (30+ min)183$23,746$92
Initial hospital care with moderate level of medical decision making at least 75 minutes95$15,564$159
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less157$13,959$25
New patient visit (60+ min)86$13,951$162
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle71$11,258$62
Injection, fulvestrant, 25 mg11$10,906None
Short return visit (20+ min)127$9,599$64
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count381$9,184$8
Blood test, comprehensive group of blood chemicals240$8,026$11
Injection, azacitidine, 1 mg14$7,642None
Cyclophosphamide, 100 mg14$7,054None
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l20$4,915$129
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes45$4,751$82
Administration of additional new drug or substance into vein, 1 hour or less58$4,680$55
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less68$4,547$55
Insertion of needle into vein for collection of blood sample343$3,321$3
Administration of additional new drug or substance into vein using push technique36$3,094$48
Injection of additional new drug or substance into vein88$2,372$13
Injection of drug or substance under skin or into muscle137$2,365$11
Administration of chemotherapy into vein using push technique14$2,341$87
Injection, palonosetron hcl, 25 mcg84$2,316None
Administration of chemotherapy into vein, each additional hour34$2,083$24
Office for the evaluation and management of established patient that may not require presence of healthcare professional85$1,998$18
Blood test, thyroid stimulating hormone (tsh)38$1,831$17
Infusion into a vein for hydration, 31-60 minutes47$1,786$26
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes26$1,767$57
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-316$1,561$21
Injection, fosaprepitant, 1 mg29$1,488None
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour26$1,350$17
Ferritin (blood protein) level62$1,349$14
Infusion into a vein for hydration, each additional hour45$1,142$10
Injection, zoledronic acid, 1 mg26$1,107None
Carcinoembryonic antigen (cea) protein level16$948$19
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg22$943None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle23$843$24
Magnesium level63$791$7
Psa (prostate specific antigen) measurement, total13$754$18
Injection, docetaxel, 1 mg11$748None
Injection, leucovorin calcium, per 50 mg18$732None
Lactate dehydrogenase (enzyme) level49$664$6
Injection, oxaliplatin, 0.5 mg14$626None
Iron binding capacity44$568$9
Injection, irinotecan, 20 mg11$509None
Injection, fluorouracil, 500 mg23$480None
Iron level45$433$6
Telephone medical discussion with physician, 5-10 minutes14$400$27
Irrigation of implanted venous access drug delivery device19$398$20
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion14$379$16
Injection, dexamethasone sodium phosphate, 1 mg120$355None
Injection, carboplatin, 50 mg19$345None
Blood test, basic group of blood chemicals (calcium, total)32$313$8
Injection, cisplatin, powder or solution, 10 mg15$245None
Injection, granisetron hydrochloride, 100 mcg45$242None
Infusion, normal saline solution , 1000 cc50$193None
Uric acid level, blood21$176$5
Urinalysis, manual test11$108$3
Phosphate level14$85$5
Injection, diphenhydramine hcl, up to 50 mg81$80None
Blood creatinine level15$77$5
Injection, magnesium sulfate, per 500 mg16$73None
Calcium level, total11$67$5
Injection, atropine sulfate, 0.01 mg11$58None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg22$45None
Infusion, normal saline solution, sterile (500 ml = 1 unit)18$38None
Unclassified drugs45$38None
Injection, mannitol, 25% in 50 ml11$23None

2020: 71 services

Original Medicare services billed in 2020
Injection, pembrolizumab, 1 mg20$226,815None
Injection, nivolumab, 1 mg12$142,383None
Injection, denosumab, 1 mg58$111,758None
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a119$105,974$159
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg25$91,433$231
Injection, darbepoetin alfa, 1 microgram (non-esrd use)43$83,503None
Injection, bortezomib, 0.1 mg18$78,519None
Unclassified biologics13$65,880None
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg13$63,451$51
Long return visit (40+ min)242$58,929$110
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg11$49,584$60
Administration of chemotherapy into vein, 1 hour or less175$34,338$105
Injection, ferric carboxymaltose, 1 mg26$18,494None
Return visit (30+ min)124$12,824$77
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less140$10,884$24
Initial hospital care with moderate level of medical decision making at least 75 minutes56$9,463$163
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count361$7,976$8
New patient visit (60+ min)47$7,272$155
Short return visit (20+ min)119$7,201$48
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle62$7,159$58
Blood test, comprehensive group of blood chemicals214$6,822$10
Injection, azacitidine, 1 mg13$6,501None
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l27$6,225$124
Administration of additional new drug or substance into vein, 1 hour or less53$4,550$53
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less63$3,914$51
Injection, fosaprepitant, 1 mg19$3,903None
Injection, palonosetron hcl, 25 mcg62$3,315None
Insertion of needle into vein for collection of blood sample346$3,040$3
Administration of additional new drug or substance into vein using push technique32$2,701$46
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes22$2,699$84
Administration of chemotherapy into vein, each additional hour49$2,614$23
Injection of drug or substance under skin or into muscle118$2,189$10
Infusion into a vein for hydration, 31-60 minutes51$2,169$26
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes25$1,981$58
Injection of additional new drug or substance into vein69$1,875$13
Office for the evaluation and management of established patient that may not require presence of healthcare professional63$1,539$17
Infusion into a vein for hydration, each additional hour56$1,465$11
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-311$1,386$21
Blood test, thyroid stimulating hormone (tsh)33$1,270$16
Ferritin (blood protein) level56$1,083$13
Injection, oxaliplatin, 0.5 mg15$941None
Psa (prostate specific antigen) measurement, total13$765$18
Injection, irinotecan, 20 mg14$692None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle22$691$21
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour18$665$17
Magnesium level42$641$7
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion22$641$16
Injection, fluorouracil, 500 mg28$622None
Irrigation of implanted venous access drug delivery device22$620$21
Lactate dehydrogenase (enzyme) level57$558$6
Iron binding capacity43$520$9
Injection, leucovorin calcium, per 50 mg25$505None
Blood test, basic group of blood chemicals (calcium, total)42$445$8
Carcinoembryonic antigen (cea) protein level12$396$19
Iron level43$392$6
Telephone medical discussion with physician, 5-10 minutes12$342$28
Injection, carboplatin, 50 mg15$335None
Injection, dexamethasone sodium phosphate, 1 mg109$256None
Infusion, normal saline solution , 1000 cc49$194None
Injection, granisetron hydrochloride, 100 mcg39$183None
Injection, etoposide, 10 mg11$170None
Uric acid level, blood19$144$4
Phosphate level13$89$4
Urinalysis, manual test15$69$3
Calcium level, total13$66$5
Injection, diphenhydramine hcl, up to 50 mg66$59None
Injection, atropine sulfate, 0.01 mg14$57None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg18$48None
Unclassified drugs36$35None
Infusion, normal saline solution, sterile (500 ml = 1 unit)17$27None
Injection, furosemide, up to 20 mg11$7None

2019: 69 services

Original Medicare services billed in 2019
Injection, pembrolizumab, 1 mg29$278,134None
Injection, nivolumab, 1 mg21$246,860None
Injection, denosumab, 1 mg87$230,268None
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg43$174,331$269
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a140$125,597$157
Injection, darbepoetin alfa, 1 microgram (non-esrd use)60$112,195None
Injection, trastuzumab, excludes biosimilar, 10 mg13$78,405None
Injection, rituximab, 10 mg14$73,204None
Injection, bortezomib, 0.1 mg21$67,586None
Long return visit (40+ min)235$50,207$107
Administration of chemotherapy into vein, 1 hour or less193$35,659$106
Injection, ferric carboxymaltose, 1 mg39$29,421None
Return visit (30+ min)140$15,260$78
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle92$12,543$60
Initial hospital care with moderate level of medical decision making at least 75 minutes68$11,303$161
Short return visit (20+ min)164$11,094$53
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less148$10,996$24
Injection, azacitidine, 1 mg16$10,320None
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count472$8,807$8
New patient visit (60+ min)55$8,478$154
Injection, palonosetron hcl, 25 mcg62$7,656None
Blood test, comprehensive group of blood chemicals293$7,194$11
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less76$4,552$52
Injection, fosaprepitant, 1 mg16$4,178None
Administration of additional new drug or substance into vein, 1 hour or less58$3,917$52
Injection of drug or substance under skin or into muscle154$3,443$12
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l16$3,204$123
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$3,072$83
Administration of chemotherapy into vein using push technique11$3,064$83
Insertion of needle into vein for collection of blood sample486$2,981$3
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes30$2,787$58
Administration of chemotherapy into vein, each additional hour51$2,735$24
Infusion into a vein for hydration, 31-60 minutes56$2,538$29
Administration of additional new drug or substance into vein using push technique26$2,156$45
Office for the evaluation and management of established patient that may not require presence of healthcare professional74$1,654$17
Injection of additional new drug or substance into vein65$1,481$13
Blood test, thyroid stimulating hormone (tsh)40$1,427$18
Infusion into a vein for hydration, each additional hour51$1,148$10
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg20$1,126None
Psa (prostate specific antigen) measurement, total19$1,062$20
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-319$907$23
Ferritin (blood protein) level39$906$15
Carcinoembryonic antigen (cea) protein level26$743$21
Injection, leucovorin calcium, per 50 mg13$646None
Injection, zoledronic acid, 1 mg15$621None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle17$572$24
Magnesium level54$532$7
Irrigation of implanted venous access drug delivery device21$485$19
Injection, oxaliplatin, 0.5 mg11$482None
Injection, carboplatin, 50 mg22$468None
Lactate dehydrogenase (enzyme) level54$467$7
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour16$403$16
Injection, granisetron hydrochloride, 100 mcg44$336None
Iron binding capacity27$333$10
Injection, fluorouracil, 500 mg16$265None
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion13$260$16
Blood test, basic group of blood chemicals (calcium, total)27$258$9
Iron level27$247$7
Injection, paclitaxel, 1 mg12$243None
Injection, dexamethasone sodium phosphate, 1 mg111$226None
Uric acid level, blood26$177$5
Infusion, normal saline solution , 1000 cc45$154None
Calcium level, total23$146$6
Blood creatinine level15$89$6
Phosphate level13$88$5
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg28$57None
Injection, diphenhydramine hcl, up to 50 mg59$39None
Infusion, normal saline solution, sterile (500 ml = 1 unit)22$36None
Unclassified drugs48$33None

2018: 72 services

Original Medicare services billed in 2018
Injection, nivolumab, 1 mg18$280,994None
Injection, denosumab, 1 mg63$203,386None
Injection, pembrolizumab, 1 mg18$190,425None
Injection, pegfilgrastim, 6 mg26$133,031None
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a137$118,854$157
Injection, rituximab, 100 mg17$109,389None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)45$98,364None
Injection, trastuzumab, excludes biosimilar, 10 mg12$80,513None
Injection, bortezomib, 0.1 mg13$54,934None
Long return visit (40+ min)229$45,426$107
Administration of chemotherapy into vein, 1 hour or less185$39,788$104
Return visit (30+ min)156$18,509$77
Injection, palonosetron hcl, 25 mcg70$16,868None
Initial hospital care with moderate level of medical decision making at least 75 minutes83$14,187$159
Injection, azacitidine, 1 mg16$12,317None
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count471$9,740$9
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle64$9,465$60
Short return visit (20+ min)130$8,830$49
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less150$8,297$24
Blood test, comprehensive group of blood chemicals334$8,243$13
Cyclophosphamide, 100 mg14$8,063None
New patient visit (60+ min)45$7,248$161
Injection, fosaprepitant, 1 mg23$6,681None
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)14$6,122$1
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes39$4,998$82
Injection of additional new drug or substance into vein107$3,721$13
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less53$3,491$52
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l19$3,369$120
Administration of additional new drug or substance into vein, 1 hour or less43$3,089$51
Injection of drug or substance under skin or into muscle101$3,038$15
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes43$3,032$57
Insertion of needle into vein for collection of blood sample479$2,943$3
Administration of chemotherapy into vein, each additional hour53$2,909$24
Administration of chemotherapy into vein using push technique14$2,806$83
Administration of additional new drug or substance into vein using push technique30$2,215$44
Infusion into a vein for hydration, 31-60 minutes41$2,169$34
Office for the evaluation and management of established patient that may not require presence of healthcare professional85$2,129$16
Blood test, thyroid stimulating hormone (tsh)47$2,033$20
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg22$1,530None
Psa (prostate specific antigen) measurement, total26$1,247$22
Infusion into a vein for hydration, each additional hour45$1,039$10
Injection, oxaliplatin, 0.5 mg16$968None
Ferritin (blood protein) level42$874$16
Injection, leucovorin calcium, per 50 mg18$842None
Carcinoembryonic antigen (cea) protein level27$803$23
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-319$731$25
Injection, zoledronic acid, 1 mg11$672None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle15$584$22
Lactate dehydrogenase (enzyme) level51$540$7
Application of on-body injector for under skin injection23$532$16
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$432$31
Injection, carboplatin, 50 mg16$415None
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour17$385$17
Unclassified drugs31$378None
Short return visit11$371$31
Magnesium level35$365$8
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion18$350$16
Irrigation of implanted venous access drug delivery device17$317$18
Injection, granisetron hydrochloride, 100 mcg55$292None
Injection, paclitaxel, 1 mg12$281None
Iron binding capacity22$264$11
Injection, doxorubicin hydrochloride, 10 mg12$238None
Injection, dexamethasone sodium phosphate, 1 mg111$226None
Iron level22$196$8
Blood test, basic group of blood chemicals (calcium, total)14$194$10
Infusion, normal saline solution , 1000 cc43$129None
Calcium level, total17$125$6
Blood creatinine level17$112$6
Uric acid level, blood12$88$5
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg18$51None
Injection, diphenhydramine hcl, up to 50 mg69$44None
Infusion, normal saline solution, sterile (500 ml = 1 unit)17$23None

2017: 66 services

Original Medicare services billed in 2017
Injection, pegfilgrastim, 6 mg59$298,102None
Injection, nivolumab, 1 mg20$253,153None
Injection, denosumab, 1 mg80$233,887None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)62$142,316None
Injection, bortezomib, 0.1 mg21$109,175None
Injection, rituximab, 100 mg17$100,443None
Injection, trastuzumab, excludes biosimilar, 10 mg11$97,851None
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a111$91,101$157
Long return visit (40+ min)239$56,148$105
Injection, fulvestrant, 25 mg11$37,725None
Administration of chemotherapy into vein, 1 hour or less157$35,531$101
Injection, ferric carboxymaltose, 1 mg33$26,247None
Return visit (30+ min)154$18,283$75
Injection, azacitidine, 1 mg13$16,434None
Injection, palonosetron hcl, 25 mcg64$16,328None
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count554$14,986$10
Initial hospital care with moderate level of medical decision making at least 75 minutes85$13,981$157
Blood test, comprehensive group of blood chemicals401$11,563$14
Short return visit (20+ min)157$11,089$49
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle81$10,865$53
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less119$9,827$23
New patient visit (60+ min)54$8,329$154
Cyclophosphamide, 100 mg13$7,277None
Injection of drug or substance under skin or into muscle167$6,833$18
Injection, fosaprepitant, 1 mg23$6,615None
Infusion into a vein for hydration, 31-60 minutes59$5,453$42
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less60$4,564$50
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes36$4,484$82
Administration of chemotherapy into vein using push technique12$4,221$83
Insertion of needle into vein for collection of blood sample552$3,808$3
Office for the evaluation and management of established patient that may not require presence of healthcare professional117$2,744$14
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l13$2,624$114
Blood test, thyroid stimulating hormone (tsh)49$2,575$23
Administration of additional new drug or substance into vein, 1 hour or less34$2,390$48
Psa (prostate specific antigen) measurement, total33$2,325$25
Administration of chemotherapy into vein, each additional hour41$2,290$21
Injection of additional new drug or substance into vein66$2,010$16
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$1,917$56
Administration of additional new drug or substance into vein using push technique20$1,867$47
Infusion into a vein for hydration, each additional hour59$1,814$11
Carcinoembryonic antigen (cea) protein level44$1,810$25
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg14$1,305None
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-322$1,203$28
Ferritin (blood protein) level49$1,155$18
Injection, zoledronic acid, 1 mg16$1,023None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle18$822$23
Short return visit23$765$32
Immunologic analysis for detection of tumor antigen, quantitative; ca 19-913$755$28
Magnesium level52$667$9
Lactate dehydrogenase (enzyme) level73$534$5
Iron binding capacity34$470$12
Injection, carboplatin, 50 mg15$465None
Irrigation of implanted venous access drug delivery device24$385$14
Iron level34$348$9
Blood test, basic group of blood chemicals (calcium, total)23$333$11
Injection, granisetron hydrochloride, 100 mcg44$329None
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion14$327$16
Calcium level, total30$267$7
Injection, dexamethasone sodium phosphate, 1 mg84$188None
Infusion, normal saline solution , 1000 cc54$187None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg21$77None
Blood creatinine level12$75$6
Uric acid level, blood14$74$4
Injection, diphenhydramine hcl, up to 50 mg58$47None
Infusion, normal saline solution, sterile (500 ml = 1 unit)21$28None
Unclassified drugs29$15None

2016: 64 services

Original Medicare services billed in 2016
Injection, pegfilgrastim, 6 mg63$307,529None
Injection, denosumab, 1 mg72$239,857None
Injection, nivolumab, 1 mg18$225,946None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)56$135,509None
Injection, bortezomib, 0.1 mg19$90,819None
Injection, bevacizumab, 10 mg11$88,298None
Injection, rituximab, 100 mg12$68,261None
Long return visit (40+ min)232$60,163$104
Injection, azacitidine, 1 mg14$47,151None
Administration of chemotherapy into vein, 1 hour or less163$41,782$100
Injection, paclitaxel protein-bound particles, 1 mg13$27,130None
Injection, palonosetron hcl, 25 mcg76$25,697None
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a38$21,482$157
Injection, levoleucovorin, not otherwise specified, 0.5 mg16$21,390None
Initial hospital care with moderate level of medical decision making at least 75 minutes124$20,158$155
Return visit (30+ min)145$17,610$76
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count268$15,601$10
Injection, ferric carboxymaltose, 1 mg18$13,644None
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle79$12,710$55
Blood test, comprehensive group of blood chemicals201$12,306$13
Short return visit (20+ min)164$10,975$49
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less115$9,089$23
New patient visit (60+ min)56$8,229$147
Injection of drug or substance under skin or into muscle153$6,699$19
Administration of chemotherapy into vein using push technique15$5,409$82
Injection, fosaprepitant, 1 mg19$5,173None
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes31$3,466$81
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less43$3,409$51
Insertion of needle into vein for collection of blood sample256$3,299$3
Administration of prolonged chemotherapy into vein15$3,115$104
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes36$2,793$56
Infusion into a vein for hydration, 31-60 minutes38$2,718$41
Psa (prostate specific antigen) measurement, total19$2,652$25
Administration of chemotherapy into vein, each additional hour49$2,637$21
Injection of additional new drug or substance into vein72$2,513$17
Administration of additional new drug or substance into vein, 1 hour or less36$2,412$46
Office for the evaluation and management of established patient that may not require presence of healthcare professional104$2,412$14
Blood test, thyroid stimulating hormone (tsh)24$2,355$22
Carcinoembryonic antigen (cea) protein level21$2,329$25
Administration of additional new drug or substance into vein using push technique23$2,213$46
Injection, zoledronic acid, 1 mg14$2,207None
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-320$2,167$28
Injection, oxaliplatin, 0.5 mg14$2,072None
Infusion into a vein for hydration, each additional hour59$2,010$11
Irrigation of implanted venous access drug delivery device54$1,102$16
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg13$905None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle13$845$24
Magnesium level34$787$9
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes21$733$31
Lactate dehydrogenase (enzyme) level55$652$5
Ferritin (blood protein) level22$582$18
Injection, carboplatin, 50 mg17$479None
Injection, granisetron hydrochloride, 100 mcg31$276None
Iron binding capacity16$245$12
Injection, dexamethasone sodium phosphate, 1 mg82$243None
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion13$232$15
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour11$213$14
Iron level16$190$9
Infusion, normal saline solution , 1000 cc35$100None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg14$96None
Blood creatinine level13$73$5
Injection, diphenhydramine hcl, up to 50 mg56$37None
Unclassified drugs29$23None
Infusion, normal saline solution, sterile (500 ml = 1 unit)11$20None

2015: 73 services

Original Medicare services billed in 2015
Injection, pegfilgrastim, 6 mg79$363,942None
Injection, denosumab, 1 mg72$202,378None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)61$152,381None
Injection, bevacizumab, 10 mg18$138,492None
Injection, rituximab, 100 mg19$108,099None
Injection, bortezomib, 0.1 mg22$104,884None
Injection, trastuzumab, excludes biosimilar, 10 mg14$96,545None
Injection, pemetrexed, not otherwise specified, 10 mg12$89,872None
Long return visit (40+ min)234$60,984$107
Injection, paclitaxel protein-bound particles, 1 mg15$48,247None
Administration of chemotherapy into vein, 1 hour or less178$41,228$100
Injection, azacitidine, 1 mg15$39,204None
Injection, palonosetron hcl, 25 mcg112$33,460None
Injection, levoleucovorin, not otherwise specified, 0.5 mg16$25,728None
Return visit (30+ min)162$19,302$78
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count213$16,872$10
Initial hospital care with moderate level of medical decision making at least 75 minutes96$16,075$158
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less156$13,463$23
Blood test, comprehensive group of blood chemicals182$12,994$13
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle83$12,613$55
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram11$12,357None
Short return visit (20+ min)175$12,284$49
New patient visit (60+ min)69$10,780$156
Unclassified drugs36$10,392None
Cyclophosphamide, 100 mg13$8,832None
Injection, fosaprepitant, 1 mg31$8,745None
Injection of drug or substance under skin or into muscle178$8,259$19
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)18$6,693$1
Injection, docetaxel, 1 mg11$6,019None
Administration of additional new drug or substance into vein, 1 hour or less66$5,665$46
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes41$5,467$79
Infusion into a vein for hydration, 31-60 minutes44$4,567$43
Injection, zoledronic acid, 1 mg19$4,458None
Administration of chemotherapy into vein, each additional hour64$3,769$21
Irrigation of implanted venous access drug delivery device114$3,728$17
Insertion of needle into vein for collection of blood sample215$3,466$3
Administration of prolonged chemotherapy into vein16$3,307$103
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less35$2,925$50
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$2,923$56
Infusion into a vein for hydration, each additional hour62$2,911$11
Administration of additional new drug or substance into vein using push technique27$2,708$46
Psa (prostate specific antigen) measurement, total20$2,702$24
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-320$2,442$28
Injection of additional new drug or substance into vein80$2,335$17
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg20$2,231None
Office for the evaluation and management of established patient that may not require presence of healthcare professional91$2,218$15
Carcinoembryonic antigen (cea) protein level17$1,816$25
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion54$1,318$16
Magnesium level40$1,170$9
Biopsy of bone marrow18$1,068$59
Injection, carboplatin, 50 mg25$902None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle11$748$24
Injection of drug or substance into vein12$632$39
Ferritin (blood protein) level22$600$18
Lactate dehydrogenase (enzyme) level50$569$5
Blood test, thyroid stimulating hormone (tsh)11$538$22
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour11$526$14
Injection, paclitaxel, 1 mg14$460None
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes13$394$30
Injection, dexamethasone sodium phosphate, 1 mg120$394None
Iron binding capacity18$303$12
Injection, granisetron hydrochloride, 100 mcg18$296None
Injection, cisplatin, powder or solution, 10 mg11$249None
Iron level19$242$9
Blood test, basic group of blood chemicals (calcium, total)12$169$11
Phosphate level13$166$4
Infusion, normal saline solution , 1000 cc50$160None
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service18$124$7
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg22$88None
Uric acid level, blood12$84$3
Injection, diphenhydramine hcl, up to 50 mg99$76None
Injection, furosemide, up to 20 mg12$36None
Infusion, normal saline solution, sterile (500 ml = 1 unit)11$15None

2014: 71 services

Original Medicare services billed in 2014
Injection, pegfilgrastim, 6 mg65$272,406None
Injection, rituximab, 100 mg26$188,305None
Injection, denosumab, 1 mg66$161,490None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)64$152,321None
Injection, bortezomib, 0.1 mg22$141,982None
Injection, bevacizumab, 10 mg15$116,961None
Injection, trastuzumab, excludes biosimilar, 10 mg13$72,633None
Long return visit (40+ min)267$63,184$105
Injection, azacitidine, 1 mg12$49,649None
Injection, paclitaxel protein-bound particles, 1 mg14$44,430None
Administration of chemotherapy into vein, 1 hour or less186$43,899$97
Injection, palonosetron hcl, 25 mcg129$39,140None
Injection, levoleucovorin, not otherwise specified, 0.5 mg11$22,848None
Cyclophosphamide, 100 mg16$16,887None
Return visit (30+ min)138$16,581$77
Initial hospital care with moderate level of medical decision making at least 75 minutes104$16,550$155
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count220$16,141$10
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less178$16,099$22
Short return visit (20+ min)176$13,381$51
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle78$12,505$54
New patient visit (60+ min)76$11,504$151
Blood test, comprehensive group of blood chemicals184$11,108$12
Injection, zoledronic acid, 1 mg24$11,105None
Injection, fosaprepitant, 1 mg34$9,603None
Injection of drug or substance under skin or into muscle174$8,310$18
Administration of additional new drug or substance into vein, 1 hour or less77$7,162$45
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes50$6,810$80
Injection, docetaxel, 1 mg12$6,776None
Administration of chemotherapy into vein, each additional hour85$5,840$21
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)17$5,439$1
Infusion into a vein for hydration, 31-60 minutes65$4,857$42
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes48$3,894$56
Administration of prolonged chemotherapy into vein14$3,483$100
Insertion of needle into vein for collection of blood sample216$3,436$3
Irrigation of implanted venous access drug delivery device97$3,360$17
Injection, oxaliplatin, 0.5 mg14$3,300None
Infusion into a vein for hydration, each additional hour74$2,964$11
Injection, fondaparinux sodium, 0.5 mg13$2,898None
Administration of additional new drug or substance into vein using push technique22$2,687$45
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-331$2,504$28
Office for the evaluation and management of established patient that may not require presence of healthcare professional100$2,486$14
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less24$2,450$49
Magnesium level57$2,339$9
Injection of additional new drug or substance into vein82$2,282$16
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg22$1,750None
Carcinoembryonic antigen (cea) protein level24$1,623$25
Psa (prostate specific antigen) measurement, total13$1,623$25
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion70$1,606$15
Injection, irinotecan, 20 mg14$1,204None
Collection of blood sample from central venous tube14$1,135$19
Injection, carboplatin, 50 mg35$1,129None
Biopsy of bone marrow16$1,002$59
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle16$916$23
Ferritin (blood protein) level35$875$18
Lactate dehydrogenase (enzyme) level67$792$5
Phosphate level47$776$4
Injection of drug or substance into vein16$740$41
Injection, paclitaxel, 30 mg24$632None
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$485$30
Iron binding capacity27$456$12
Injection, dexamethasone sodium phosphate, 1 mg132$452None
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour13$427$13
Iron level27$346$9
Injection, granisetron hydrochloride, 100 mcg22$229None
Infusion, normal saline solution , 1000 cc64$139None
Injection, diphenhydramine hcl, up to 50 mg109$101None
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service14$96$7
Uric acid level, blood17$95$3
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg19$78None
Unclassified drugs44$47None
Infusion, normal saline solution, sterile (500 ml = 1 unit)14$25None

2013: 77 services

Original Medicare services billed in 2013
Injection, pegfilgrastim, 6 mg71$228,974None
Injection, rituximab, 100 mg31$182,557None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)50$116,177None
Injection, azacitidine, 1 mg13$105,105None
Injection, denosumab, 1 mg37$101,024None
Injection, pemetrexed, not otherwise specified, 10 mg13$89,385None
Injection, bevacizumab, 10 mg12$76,219None
Injection, bortezomib, 0.1 mg11$70,156None
Long return visit (40+ min)282$69,899$104
Unclassified drugs51$69,106None
Administration of chemotherapy into vein, 1 hour or less203$60,351$104
Injection, palonosetron hcl, 25 mcg140$49,589None
Injection, paclitaxel protein-bound particles, 1 mg17$48,274None
Injection, levoleucovorin, not otherwise specified, 0.5 mg16$30,476None
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less188$20,956$23
Injection, docetaxel, 1 mg17$18,707None
Injection, fosaprepitant, 1 mg47$15,866None
Return visit (30+ min)140$15,820$76
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count208$15,817$11
Injection, zoledronic acid (zometa), 1 mg15$14,675None
Cyclophosphamide, 100 mg19$13,130None
Initial hospital care with moderate level of medical decision making at least 75 minutes69$10,858$153
Zoldedronic acid 1mg14$10,809$140
Blood test, comprehensive group of blood chemicals175$10,422$12
Injection, oxaliplatin, 0.5 mg14$10,331None
New patient visit (60+ min)65$9,834$151
Short return visit (20+ min)144$9,688$51
Administration of additional new drug or substance into vein, 1 hour or less81$8,285$52
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle45$7,287$55
Administration of chemotherapy into vein, each additional hour92$7,127$23
Injection of drug or substance under skin or into muscle157$6,340$19
Administration of chemotherapy into vein using push technique14$5,542$81
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes45$5,527$78
Administration of prolonged chemotherapy into vein18$4,148$104
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg25$3,492None
Injection of additional new drug or substance into vein104$3,351$16
Insertion of needle into vein for collection of blood sample204$3,258$3
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)11$3,181$1
Collection of blood sample from central venous tube19$3,141$20
Administration of additional new drug or substance into vein using push technique30$3,105$46
Irrigation of implanted venous access drug delivery device80$2,895$18
Infusion into a vein for hydration, each additional hour46$2,555$11
Magnesium level66$2,467$9
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-330$2,368$28
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less21$2,313$55
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes31$2,107$54
Office for the evaluation and management of established patient that may not require presence of healthcare professional98$1,955$15
Psa (prostate specific antigen) measurement, total15$1,767$25
Infusion into a vein for hydration, 31-60 minutes25$1,411$42
Injection, irinotecan, 20 mg14$1,382None
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion62$1,361$14
Injection, carboplatin, 50 mg35$1,318None
Biopsy of bone marrow21$1,302$57
Carcinoembryonic antigen (cea) protein level14$1,233$26
Phosphate level52$893$4
Lactate dehydrogenase (enzyme) level68$883$5
Injection, paclitaxel, 30 mg20$874None
Ferritin (blood protein) level27$719$18
Injection of drug or substance into vein14$629$42
Injection, doxorubicin hydrochloride, 10 mg12$553None
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes17$528$29
Injection, dexamethasone sodium phosphate, 1 mg141$449None
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle14$430$24
Injection, etoposide, 10 mg16$403None
Injection, granisetron hydrochloride, 100 mcg24$391None
Iron binding capacity27$379$12
Iron level29$307$9
Injection, cisplatin, powder or solution, 10 mg11$266None
Blood test, basic group of blood chemicals (calcium, total)14$240$11
Uric acid level, blood17$158$3
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service21$150$7
Injection, diphenhydramine hcl, up to 50 mg107$126None
Injection, fluorouracil, 500 mg14$92None
Infusion, normal saline solution , 1000 cc31$50None
Injection, furosemide, up to 20 mg12$42None
Injection, atropine sulfate, 0.01 mg11$25None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg22$22None

Medicaid work

$219 in 2024

Medicaid paid $219 for 37 billed services this clinician did in 2024, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
COMPREHENSIVE METABOLIC PANEL17$138
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count20$81
Medicaid work by year
202437213$219
2023174419$2,631
202213113$722
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug15$1,509
Long return visit (40+ min)16$427
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count108$417
COMPREHENSIVE METABOLIC PANEL35$278

2022

Largest Medicaid services in 2022
Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug13$722

Drugs they prescribed that Part D paid

$1,006,016

Pharmacies billed $1,006,016 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 2% of their Part D prescriptions (16 of 737) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.

647 generic and 90 brand-name prescriptions · $1,006,016 in drug cost · 29 antibiotic prescriptions to 22 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Nubeqa13$168,884$12,991
Lenalidomide12$159,990$13,333
Eliquis11$7,004$637
Anastrozole160$3,443$22
Tamoxifen Citrate30$646$22
See all 17 drugs
Every Part D drug this clinician prescribed
Nubeqa13$168,884$12,991
Lenalidomide12$159,990$13,333
Eliquis11$7,004$637
Anastrozole160$3,443$22
Tamoxifen Citrate30$646$22
Dexamethasone55$624$11
Acyclovir43$537$12
Hydroxyurea19$471$25
Letrozole30$420$14
Prochlorperazine Maleate26$337$13
Ondansetron22$330$15
Gabapentin15$327$22
Levothyroxine17$185$11
Duloxetine13$117$9
Prednisone26$106$4
Anagrelide12$79$7
Pantoprazole11$79$7

Year by year

Part D prescribing by year
20247372242% (16)12%$1,006,016
20231,3992632% (32)None$956,460
20221,4652633% (45)None$745,665
20211,1842302% (23)8%$572,343
20201,1612113% (31)7%$488,259
20199492166% (59)9%$363,748
20189072259% (83)None$630,543
20171,0552188% (85)None$579,559
20161,1912338% (97)16%$1,001,464
20151,1032177% (76)None$1,105,108
20141,0432269% (94)None$774,065
20131,15820711% (123)18%$1,001,917

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 29 drugs

Part D drugs prescribed in 2023
Everolimus12$136,874$11,406
Abiraterone Acetate24$61,327$2,555
Xarelto25$20,244$810
Eliquis29$16,665$575
Anastrozole262$5,677$22
Exemestane23$5,296$230
Enoxaparin14$3,029$216
Tamoxifen Citrate53$2,020$38
Gabapentin63$1,574$25
Dexamethasone112$1,325$12
Letrozole47$994$21
Hydroxyurea47$888$19
Acyclovir61$657$11
Prednisone94$629$7
Prochlorperazine Maleate50$544$11
Levothyroxine46$500$11
Duloxetine20$407$20
Oxycodone15$379$25
Ondansetron Odt22$347$16
Anagrelide24$260$11
Omeprazole18$202$11
Pantoprazole19$201$11
Potassium Chloride14$169$12
Celecoxib11$148$13
Alendronate18$94$5
Levofloxacin12$67$6
Sulfamethoxazole-Trimethoprim20$67$3
Furosemide16$61$4
Folic Acid13$20$2

2022: 27 drugs

Part D drugs prescribed in 2022
Ibrance11$149,874$13,625
Abiraterone Acetate14$47,539$3,396
Xarelto19$18,170$956
Eliquis28$17,043$609
Anastrozole257$7,327$29
Exemestane17$7,256$427
Dexamethasone143$2,131$15
Tamoxifen Citrate48$1,714$36
Letrozole66$1,199$18
Gabapentin55$954$17
Doxycycline Hyclate14$849$61
Hydroxyurea58$799$14
Acyclovir64$699$11
Prednisone132$659$5
Bicalutamide15$641$43
Anagrelide12$596$50
Ondansetron Odt22$490$22
Prochlorperazine Maleate69$449$7
Oxycodone16$325$20
Pantoprazole24$275$11
Ondansetron17$246$14
Levothyroxine26$204$8
Finasteride12$183$15
Potassium Chloride12$152$13
Omeprazole18$125$7
Alendronate25$64$3
Furosemide11$57$5

2021: 25 drugs

Part D drugs prescribed in 2021
Calquence11$155,559$14,142
Xarelto21$14,276$680
Eliquis18$10,328$574
Anastrozole253$7,458$29
Exemestane17$4,837$285
Enoxaparin13$2,520$194
Tamoxifen Citrate51$1,710$34
Dexamethasone124$1,360$11
Hydroxyurea62$1,138$18
Gabapentin41$929$23
Potassium Chloride22$796$36
Letrozole32$627$20
Bicalutamide16$582$36
Prochlorperazine Maleate65$499$8
Sucralfate14$470$34
Acyclovir36$297$8
Cephalexin11$283$26
Ondansetron Odt20$280$14
Ondansetron15$274$18
Pantoprazole13$266$20
Omeprazole29$263$9
Prednisone61$206$3
Levothyroxine17$53$3
Cyclobenzaprine11$45$4
Alendronate20$24$1

2020: 20 drugs

Part D drugs prescribed in 2020
Xarelto20$13,356$668
Enoxaparin12$6,423$535
Exemestane17$5,354$315
Anagrelide12$5,198$433
Anastrozole262$4,708$18
Potassium Chloride28$3,609$129
Dexamethasone196$2,523$13
Tamoxifen Citrate44$1,718$39
Hydroxyurea33$850$26
Letrozole20$776$39
Prochlorperazine Maleate65$590$9
Prednisone71$350$5
Gabapentin27$325$12
Ondansetron21$297$14
Acyclovir49$267$5
Ondansetron Odt12$206$17
Finasteride12$184$15
Cephalexin13$77$6
Zolpidem12$50$4
Levofloxacin15$41$3

2019: 19 drugs

Part D drugs prescribed in 2019
Exemestane26$7,284$280
Potassium Chloride29$6,097$210
Enoxaparin12$5,939$495
Anastrozole197$4,704$24
Tamoxifen Citrate29$1,800$62
Hydroxyurea36$1,101$31
Dexamethasone82$942$11
Letrozole16$935$58
Hydrocodone-Acetaminophen14$717$51
Bicalutamide11$524$48
Gabapentin33$394$12
Prochlorperazine Maleate37$314$8
Ondansetron Odt11$286$26
Acyclovir29$229$8
Prednisone56$203$4
Finasteride12$188$16
Ondansetron14$157$11
Zolpidem19$58$3
Jantoven22$25$1

2018: 19 drugs

Part D drugs prescribed in 2018
Enoxaparin13$17,668$1,359
Exemestane14$6,524$466
Potassium Chloride29$5,759$199
Anastrozole202$3,711$18
Tamoxifen Citrate62$2,172$35
Hydroxyurea41$1,280$31
Oxycodone27$785$29
Hydrocodone-Acetaminophen18$709$39
Dexamethasone64$567$9
Letrozole11$344$31
Prednisone53$338$6
Prochlorperazine Maleate35$324$9
Ondansetron13$305$23
Citalopram Hbr15$253$17
Acyclovir21$177$8
Gabapentin15$147$10
Sulfamethoxazole-Trimethoprim19$133$7
Ondansetron Odt13$107$8
Levofloxacin12$67$6

2017: 21 drugs

Part D drugs prescribed in 2017
Revlimid12$160,346$13,362
Pradaxa16$5,952$372
Exemestane12$5,340$445
Potassium Chloride32$5,050$158
Anastrozole230$3,299$14
Tamoxifen Citrate82$2,527$31
Fentanyl11$1,536$140
Hydroxyurea38$1,311$35
Oxycodone26$795$31
Dexamethasone108$661$6
Prochlorperazine Maleate61$451$7
Hydrocodone-Acetaminophen11$406$37
Ondansetron14$378$27
Ondansetron Odt19$325$17
Zolpidem28$238$8
Prednisone34$219$6
Letrozole13$208$16
Acyclovir29$197$7
Omeprazole19$128$7
Levofloxacin13$106$8
Lorazepam14$63$5

2016: 24 drugs

Part D drugs prescribed in 2016
Revlimid12$136,233$11,353
Xtandi15$134,786$8,986
Imbruvica11$111,928$10,175
Zytiga11$93,929$8,539
Anastrozole257$3,761$15
Tamoxifen Citrate69$2,033$29
Hydroxyurea43$1,031$24
Hydrocodone-Acetaminophen18$683$38
Oxycodone19$633$33
Prochlorperazine Maleate70$476$7
Letrozole27$434$16
Dexamethasone88$357$4
Klor-Con M2018$350$19
Hydromorphone12$298$25
Zolpidem21$280$13
Diphenoxylate-Atropine12$273$23
Warfarin13$273$21
Acyclovir28$260$9
Omeprazole33$244$7
Prednisone28$224$8
Lorazepam23$167$7
Alendronate11$135$12
Pantoprazole23$134$6
Potassium Chloride19$81$4

2015: 20 drugs

Part D drugs prescribed in 2015
Revlimid36$356,222$9,895
Tasigna13$210,148$16,165
Promacta11$17,030$1,548
Anastrozole212$3,678$17
Tamoxifen Citrate87$2,943$34
Methotrexate11$1,916$174
Hydroxyurea43$1,420$33
Hydromorphone12$610$51
Oxycodone17$592$35
Dexamethasone97$468$5
Hydrocodone-Acetaminophen14$424$30
Zolpidem22$279$13
Acyclovir42$274$7
Prochlorperazine Maleate69$269$4
Potassium Chloride12$259$22
Letrozole12$226$19
Levofloxacin15$214$14
Omeprazole29$191$7
Alendronate18$178$10
Pantoprazole16$68$4

2014: 22 drugs

Part D drugs prescribed in 2014
Revlimid26$258,474$9,941
Zytiga15$104,891$6,993
Tarceva12$72,767$6,064
Anastrozole205$5,444$27
Carafate13$2,412$186
Tamoxifen Citrate67$1,950$29
Hydroxyurea28$1,023$37
Oxycodone27$972$36
Methotrexate13$911$70
Oxycodone-Acetaminophen15$520$35
Dexamethasone90$497$6
Acyclovir37$298$8
Hydrocodone-Acetaminophen15$287$19
Prednisone40$284$7
Prochlorperazine Maleate55$267$5
Potassium Chloride14$223$16
Alendronate18$199$11
Zolpidem18$154$9
Levofloxacin16$153$10
Lorazepam16$100$6
Ibuprofen19$91$5
Pantoprazole12$87$7

2013: 26 drugs

Part D drugs prescribed in 2013
Revlimid46$466,698$10,146
Zytiga15$74,263$4,951
Oxycontin17$8,367$492
Anastrozole206$7,367$36
Fentanyl17$3,564$210
Oxycodone30$1,723$57
Escitalopram32$1,384$43
Tamoxifen Citrate56$1,244$22
Letrozole22$1,093$50
Methotrexate13$1,074$83
Hydroxyurea21$892$42
Megestrol Acetate17$752$44
Hydromorphone14$743$53
Levofloxacin27$352$13
Dexamethasone73$332$5
Acyclovir25$311$12
Prochlorperazine Maleate64$309$5
Oxycodone-Acetaminophen15$306$20
Prednisone51$224$4
Alendronate14$199$14
Ondansetron12$189$16
Pantoprazole11$178$16
Lorazepam19$120$6
Fluconazole11$94$9
Cephalexin12$93$8
Zolpidem11$65$6

Money from drug and device companies

$13 in 2024

Industry payments by year
202411None$13
202333None$38
2022914None$269
20211830None$407
20201524None$575
20191159None$596

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Fresenius Kabi USAStimufend$13
1 payment
  • Meals for Stimufend · 2024-01-18 · $13
See the published payment
Every published payment
Fresenius Kabi USAMeals · 2024-01-18Stimufend$13
See earlier years (2023, 2022, 2021, 2020, 2019)

2023: $38

Payments by company in 2023
CelgeneReblozyl$15
1 payment
  • Meals for Reblozyl · 2023-07-12 · $15
AstraZeneca Pharmaceuticals LPEnhertu$13
1 payment
  • Meals for Enhertu · 2023-04-14 · $13
Rigel PharmaceuticalsRezlidhia$9
1 payment
  • Meals for Rezlidhia · 2023-03-07 · $9

2022: $269

Payments by company in 2022
E.R. Squibb & Sons L.L.C.Opdivo$134
5 payments
  • Meals for Opdivo · 2022-08-08 · $11
  • Meals for Opdivo · 2022-07-15 · $10
  • Meals for Opdivo · 2022-04-01 · $94
  • Meals for Opdivo · 2022-03-08 · $10
  • Meals for Opdivo · 2022-01-10 · $10
Agios PharmaceuticalsPyrukynd$25
1 payment
  • Meals for Pyrukynd · 2022-11-02 · $25
Daiichi SankyoEnhertu$24
2 payments
  • Meals for Turalio · 2022-11-16 · $12
  • Meals for Enhertu · 2022-04-26 · $12
AbbvieVenclexta$17
1 payment
  • Meals for Venclexta · 2022-03-05 · $17
Array BiopharmaBraftovi$16
1 payment
  • Meals for Braftovi · 2022-10-17 · $16
BeiGene USABrukinsa$14
1 payment
  • Meals for Brukinsa · 2022-11-11 · $14
Bayer HealthCare PharmaceuticalsNubeqa$14
1 payment
  • Meals for Nubeqa · 2022-04-12 · $14
EUSA Pharma (US)Sylvant$12
1 payment
  • Meals for Sylvant · 2022-03-18 · $12
AVEO PharmaceuticalsFotivda$12
1 payment
  • Meals for Fotivda · 2022-09-08 · $12

2021: $407

Payments by company in 2021
Janssen BiotechErleada$67
6 payments
  • Meals for Rybrevant · 2021-08-26 · $21
  • Meals for Erleada · 2021-06-04 · $12
  • Meals for Erleada · 2021-05-26 · $0
  • Meals for Erleada · 2021-05-11 · $9
  • Meals for Erleada · 2021-04-24 · $13
  • Meals for Erleada · 2021-03-11 · $12
SeagenTukysa$61
2 payments
  • Education for Tukysa · 2021-04-20 · $50
  • Meals for Padcev · 2021-03-19 · $11
Janssen PharmaceuticalsXarelto$58
4 payments
  • Meals for Xarelto · 2021-09-23 · $21
  • Meals for Xarelto · 2021-07-10 · $17
  • Education for Erleada · 2021-04-20 · $9
  • Meals for Xarelto · 2021-03-17 · $11
Global Blood TherapeuticsOxbryta$40
3 payments
  • Meals for Oxbryta · 2021-10-25 · $15
  • Meals for Oxbryta · 2021-07-15 · $13
  • Meals for Oxbryta · 2021-04-19 · $13
AbbVieVenclexta$27
2 payments
  • Meals for Venclexta · 2021-07-13 · $15
  • Meals for Venclexta · 2021-03-27 · $12
Daiichi SankyoInjectafer$13
1 payment
  • Meals for Injectafer · 2021-01-26 · $13
Foundation MedicineFoundationone$12
1 payment
  • Meals for Foundationone · 2021-08-20 · $12
TerSera TherapeuticsZoladex$12
1 payment
  • Meals for Zoladex · 2021-09-10 · $12
Regeneron Healthcare SolutionsLibtayo$12
1 payment
  • Meals for Libtayo · 2021-04-07 · $12
Gilead SciencesNone$12
1 payment
  • Education · 2021-06-01 · $12
Aveo PharmaceuticalsFotivda$12
1 payment
  • Meals for Fotivda · 2021-10-07 · $12
EMD SeronoNone$12
1 payment
  • Meals · 2021-12-02 · $12
Acrotech BiopharmaZevalin$12
1 payment
  • Meals for Zevalin · 2021-01-22 · $12
Pharmacyclics LLC An AbbVieImbruvica$12
1 payment
  • Meals for Imbruvica · 2021-07-22 · $12
Bayer HealthCare PharmaceuticalsNubeqa$12
1 payment
  • Meals for Nubeqa · 2021-12-13 · $12
GenzymeCablivi$12
1 payment
  • Meals for Cablivi · 2021-04-22 · $12
BeiGene USABrukinsa$11
1 payment
  • Meals for Brukinsa · 2021-08-09 · $11
Janssen Scientific AffairsDarzalex$11
1 payment
  • Meals for Darzalex · 2021-03-04 · $11

2020: $575

Payments by company in 2020
EpizymeTazverik$147
2 payments
  • Meals for Tazverik · 2020-07-30 · $123
  • Meals for Tazverik · 2020-07-30 · $25
Janssen BiotechErleada$124
4 payments
  • Meals for Erleada · 2020-06-11 · $16
  • Meals for Imbruvica · 2020-04-28 · $10
  • Education for Erleada · 2020-01-10 · $85
  • Meals for Erleada · 2020-01-10 · $13
Astellas Pharma USNone$85
1 payment
  • Education · 2020-05-01 · $85
AbbVieVenclexta$36
3 payments
  • Meals for Venclexta · 2020-11-19 · $14
  • Meals for Venclexta · 2020-09-15 · $11
  • Meals for Venclexta · 2020-08-22 · $11
Bayer HealthCare PharmaceuticalsNubeqa$29
2 payments
  • Meals for Stivarga · 2020-12-28 · $13
  • Meals for Nubeqa · 2020-04-06 · $17
GlaxoSmithKlineZejula$23
1 payment
  • Meals for Zejula · 2020-04-14 · $23
Genentech USAPerjeta$22
2 payments
  • Meals for Perjeta · 2020-04-28 · $11
  • Meals for Perjeta · 2020-02-17 · $11
Janssen PharmaceuticalsXarelto$17
2 payments
  • Meals for Xarelto · 2020-08-10 · $9
  • Meals for Xarelto · 2020-02-05 · $9
Octapharma USAOctagam Immune Globulin (Human)$17
1 payment
  • Meals for Octagam Immune Globulin (Human) · 2020-01-30 · $17
AstraZeneca Pharmaceuticals LPNone$14
1 payment
  • Meals · 2020-12-18 · $14
GenzymeElitek$12
1 payment
  • Meals for Elitek · 2020-03-02 · $12
Global Blood TherapeuticsOxbryta$12
1 payment
  • Meals for Oxbryta · 2020-08-18 · $12
Janssen Scientific AffairsDarzalex$12
1 payment
  • Meals for Darzalex · 2020-08-07 · $12
Karyopharm TherapeuticsXpovio$12
1 payment
  • Meals for Xpovio · 2020-05-20 · $12
Aurobindo Pharma USAMarqibo$11
1 payment
  • Meals for Marqibo · 2020-07-31 · $11

2019: $596

Payments by company in 2019
PfizerXtandi$132
23 payments
  • Meals for Inlyta · 2019-12-17 · $10
  • Meals for Ibrance · 2019-11-26 · $10
  • Meals for Inlyta · 2019-11-20 · $10
  • Meals for Xtandi · 2019-11-07 · $7
  • Meals for Xtandi · 2019-11-06 · $0
  • Meals for Xtandi · 2019-09-10 · $8
  • Meals for Xtandi · 2019-09-06 · $10
  • Meals for Ibrance · 2019-08-15 · $9
  • Meals for Ibrance · 2019-08-15 · $2
  • Meals for Xalkori · 2019-07-25 · $10
  • Meals for Xtandi · 2019-06-24 · $1
  • Meals for Xtandi · 2019-06-24 · $9
  • Meals for Xalkori · 2019-03-25 · $0
  • Meals for Xalkori · 2019-03-25 · $10
  • Meals for Sutent · 2019-03-01 · $9
  • Meals for Bosulif · 2019-02-28 · $0
  • Meals for Bosulif · 2019-02-28 · $8
  • Meals for Xtandi · 2019-02-01 · $0
  • Meals for Xtandi · 2019-02-01 · $8
  • Meals for Sutent · 2019-01-22 · $1
  • Meals for Ibrance · 2019-01-17 · $9
  • Meals for Xtandi · 2019-01-07 · $0
  • Meals for Xtandi · 2019-01-07 · $1
E.R. Squibb & Sons L.L.C.Opdivo$110
15 payments
  • Meals · 2019-12-12 · $10
  • Meals for Opdivo · 2019-11-15 · $10
  • Meals for Opdivo · 2019-10-30 · $5
  • Meals for Opdivo · 2019-10-04 · $3
  • Meals for Eliquis · 2019-09-09 · $10
  • Meals for Opdivo · 2019-09-05 · $12
  • Meals for Opdivo · 2019-09-05 · $0
  • Meals for Opdivo · 2019-08-29 · $4
  • Meals for Opdivo · 2019-06-07 · $0
  • Meals for Opdivo · 2019-06-07 · $14
  • Meals for Opdivo · 2019-04-18 · $10
  • Meals for Opdivo · 2019-03-14 · $9
  • Meals for Opdivo · 2019-02-15 · $10
  • Meals for Opdivo · 2019-02-15 · $0
  • Meals for Empliciti · 2019-01-10 · $13
Sun Pharmaceutical IndustriesYonsa$86
1 payment
  • Meals for Yonsa · 2019-02-22 · $86
Janssen BiotechErleada$76
8 payments
  • Meals for Erleada · 2019-10-28 · $13
  • Meals for Imbruvica · 2019-09-24 · $7
  • Meals for Imbruvica · 2019-09-06 · $3
  • Meals for Erleada · 2019-09-05 · $3
  • Meals for Erleada · 2019-07-19 · $12
  • Meals for Imbruvica · 2019-05-07 · $13
  • Meals for Erleada · 2019-04-16 · $13
  • Meals for Imbruvica · 2019-03-28 · $12
Puma BiotechnologyNerlynx$69
1 payment
  • Meals for Nerlynx · 2019-05-21 · $69
Janssen PharmaceuticalsXarelto$38
5 payments
  • Meals for Xarelto · 2019-11-12 · $10
  • Meals for Xarelto · 2019-09-06 · $3
  • Education for Erleada · 2019-08-20 · $9
  • Meals for Xarelto · 2019-07-16 · $8
  • Meals for Xarelto · 2019-02-07 · $8
Lexicon PharmaceuticalsXermelo$25
2 payments
  • Meals for Xermelo · 2019-11-18 · $11
  • Meals for Xermelo · 2019-07-08 · $13
Jazz PharmaceuticalsVyxeos$20
1 payment
  • Meals for Vyxeos · 2019-05-28 · $20
Janssen Scientific AffairsDarzalex$19
1 payment
  • Meals for Darzalex · 2019-07-16 · $19
CelgeneInrebic$11
1 payment
  • Meals for Inrebic · 2019-10-31 · $11
AMAG PharmaceuticalsFeraheme$11
1 payment
  • Education for Feraheme · 2019-09-23 · $11

Professional record

NPI
1871592154
Licence
PA MD070951L
Group
Monterey Bay Oncology A Medical Corporation · Dignity Health Medical Foundation
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0003X (207RH0003X)
Mailing address
15400 National Ave Ste 201, Los Gatos, CA, 95032
NPI first listed
2005-07-19
NPI last updated
2026-05-14
NPI record certified
2026-05-14

This is when the NPI record was last certified, not a medical board exam.